Effects of Treatment of Chronic Stress in Patients With Lupus
NCT00483613 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45
Last updated 2007-06-07
Summary
* Daily stress can worsens the clinical course of lupus.
* Objective: to determine the efficacy of the stress management therapy in a group of patients with lupus.
* 45 patients with lupus and high daily stress participated in this clinical trial.
* Two groups resulted: a control group (CG) that received the usual care and a therapy group (TG) that received a cognitive behavioral therapy.
* The therapy consisted of ten consecutive weekly sessions.
* The measured variables were psychological, clinical, immunological and quality of life. At the basal moment and after 3, 9 and 15 months.
* Statistical analysis showed a significant reduction in the levels of depression, anxiety and daily stress in the therapy group, compared to the usual care group, a significant improvement in quality of life, improvements in the reported symptoms (cardiovascular, respiratory, cutaneous and musculoskeletal.
Conditions
Interventions
- BEHAVIORAL
-
Cognitive-behavioral therapy of Meichenbaum
Sponsors & Collaborators
-
University Hospital Virgen de las Nieves
lead OTHER
Principal Investigators
-
Jiménez Juan, PhD, MD
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-12-31
- Completion
- 2005-07-31
Countries
- Spain
Study Locations
More Related Trials
-
Improving Quality of Life for African American Female Adolescents With Lupus
NCT00068874 ·Status: COMPLETED ·Phase: PHASE2
-
Contemplation-Based Intervention and Health Outcomes RCT in Lupus Patients
NCT04032496 ·Status: UNKNOWN ·Phase: NA
-
Healthy Lifestyle Intervention in Patients with Systemic Lupus Erythematosus: the Living Well with Lupus Study
NCT04431167 ·Status: COMPLETED ·Phase: NA
-
Psycho-social Consequences of Systemic Lupus Erythematosus
NCT03913754 ·Status: COMPLETED
-
Longitudinal Study of Quality of Life and Activity in Systemic Lupus Erythematosus
NCT01904812 ·Status: COMPLETED ·Phase: NA
-
Immune Response to SARS-CoV-2 Vaccination in Systemic Lupus
NCT04894253 ·Status: TERMINATED
-
Gradual Withdrawal of Low-dose Glucocorticoid in Clinically Quiescent Systemic Lupus Erythematosus.
NCT06234852 ·Status: COMPLETED ·Phase: NA
-
Teams Engaged in Accessible Mental Health Interventions for Lupus Erythematosus and Dermatomyositis Stress
NCT06999109 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Characterizing Adherence to Treatment and Satisfaction With Care in Patients With Cutaneous Lupus
NCT06506214 ·Status: COMPLETED
-
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
NCT00342095 ·Status: COMPLETED
-
Use of Social Media to Improve Medication Adherence in Adolescents and Young Adults With Systemic Lupus
NCT03218033 ·Status: COMPLETED ·Phase: NA
-
Reducing Depressive Symptoms in Systemic Lupus Erythematosus
NCT01120652 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus
NCT00482989 ·Status: COMPLETED ·Phase: PHASE1
-
Multicomponent Strategy to Implement a Clinical Practice Guideline and Improve Health Outcomes in People With SLE
NCT03537638 ·Status: COMPLETED ·Phase: NA
-
Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis
NCT05207358 ·Status: RECRUITING ·Phase: PHASE4
-
Motivating Individuals With Lupus to Exercise
NCT05287581 ·Status: COMPLETED ·Phase: NA
-
Individualized Patient Decision Making for Treatment Choices Among Minorities With Lupus
NCT02319525 ·Status: COMPLETED ·Phase: NA
-
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
NCT00339261 ·Status: COMPLETED
-
PRediction Of Flares In Lupus With autoantibodiEs and Chemokines
NCT04951427 ·Status: UNKNOWN
-
Assessment of Anxiety, Depression, Sleep Quality and Quality of Life in Systemic Lupus Erythematosus Patients
NCT05971498 ·Status: UNKNOWN
-
Lupus and Observance
NCT03019926 ·Status: COMPLETED
-
Effects of an Intervention With EVOO and Physical Activity in Patients With Systemic Lupus Erythematosus
NCT05261529 ·Status: UNKNOWN ·Phase: NA
-
A Non-drug Study Profiling Cutaneous Lupus
NCT01923415 ·Status: COMPLETED
-
Abnormalities of B Lymphocytes During Systemic Lupus
NCT00401141 ·Status: COMPLETED ·Phase: NA
-
Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors
NCT00519363 ·Status: COMPLETED ·Phase: PHASE1/PHASE2